{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:09:39Z","timestamp":1795118979511,"version":"4.10.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Women with ductal carcinoma in situ (DCIS) have an increased risk of progression to invasive breast cancer. Although not all women with DCIS will progress to invasion, all are treated as such, emphasising the need to identify prognostic biomarkers. We have previously shown that altered myoepithelial cells in DCIS predict disease progression and recurrence. By analysing DCIS duct size in sections of human breast tumour samples, we identified an associated upregulation of integrin \u03b26 and an increase in periductal fibronectin deposition with increased DCIS duct size that associated with the progression of DCIS to invasion. Our modelling of the mechanical stretching myoepithelial cells undergo during DCIS progression confirmed the upregulation of integrin \u03b26 and fibronectin expression in isolated primary and cell line models of normal myoepithelial cells. Our studies reveal that this mechanostimulated DCIS myoepithelial cell phenotype enhances invasion in a TGF\u03b2-mediated upregulation of MMP13. Immunohistochemical analysis identified that MMP13 was specifically upregulated in DCIS, and it was associated with progression to invasion. These findings implicate tissue mechanics in altering the myoepithelial cell phenotype in DCIS, and that these alterations may be used to stratify DCIS patients into low and high risk for invasive progression.<\/jats:p>","DOI":"10.1038\/s41523-022-00464-4","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T10:13:55Z","timestamp":1663668835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-5046","authenticated-orcid":false,"given":"Mary-Kate","family":"Hayward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-8087","authenticated-orcid":false,"given":"Michael D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Gomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin M.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-3274","authenticated-orcid":false,"given":"J. Louise","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"464_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.pathol.4.110807.092306","volume":"5","author":"DC Sgroi","year":"2010","unstructured":"Sgroi, D. C. Preinvasive breast cancer. Annu Rev. Pathol. 5, 193\u2013221 (2010).","journal-title":"Annu Rev. Pathol."},{"key":"464_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0011-3840(05)80019-X","volume":"33","author":"CJ Swallow","year":"1996","unstructured":"Swallow, C. J., Van Zee, K. J., Sacchini, V. & Borgen, P. I. Ductal carcinoma in situ of the breast: progress and controversy. Curr. Probl. Surg. 33, 553\u2013600 (1996).","journal-title":"Curr. Probl. Surg."},{"key":"464_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-008-0067-5","volume":"115","author":"LN van Steenbergen","year":"2009","unstructured":"van Steenbergen, L. N. et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 115, 181\u2013183 (2009).","journal-title":"Breast Cancer Res Treat."},{"key":"464_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","volume":"2010","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske, K. Epidemiology of ductal carcinoma in situ. J. Natl Cancer Inst. Monogr. 2010, 139\u2013141 (2010).","journal-title":"J. Natl Cancer Inst. Monogr."},{"key":"464_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen, M. et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br. J. Cancer 121, 285\u2013292 (2019).","journal-title":"Br. J. Cancer"},{"key":"464_CR6","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/cncr.20979","volume":"103","author":"LC Collins","year":"2005","unstructured":"Collins, L. C. et al. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses\u2019 Health Study. Cancer 103, 1778\u20131784 (2005).","journal-title":"Cancer"},{"key":"464_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","volume":"97","author":"B Erbas","year":"2006","unstructured":"Erbas, B., Provenzano, E., Armes, J. & Gertig, D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 97, 135\u2013144 (2006).","journal-title":"Breast Cancer Res Treat."},{"key":"464_CR8","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders, M. E., Schuyler, P. A., Dupont, W. D. & Page, D. L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103, 2481\u20132484 (2005).","journal-title":"Cancer"},{"key":"464_CR9","first-page":"1","volume":"26","author":"CJ Allegra","year":"2009","unstructured":"Allegra, C. J. et al. NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). NIH Consens. State Sci. Statements 26, 1\u201327 (2009).","journal-title":"NIH Consens. State Sci. Statements"},{"key":"464_CR10","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-05-4083","volume":"66","author":"J Yao","year":"2006","unstructured":"Yao, J. et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 66, 4065\u20134078 (2006).","journal-title":"Cancer Res"},{"key":"464_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2157","volume":"10","author":"NP Castro","year":"2008","unstructured":"Castro, N. P. et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 10, R87 (2008).","journal-title":"Breast Cancer Res"},{"key":"464_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ng1409","volume":"36","author":"K Chin","year":"2004","unstructured":"Chin, K. et al. In situ analyses of genome instability in breast cancer. Nat. Genet 36, 984\u2013988 (2004).","journal-title":"Nat. Genet"},{"key":"464_CR13","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","volume":"100","author":"XJ Ma","year":"2003","unstructured":"Ma, X. J. et al. Gene expression profiles of human breast cancer progression. Proc. Natl Acad. Sci. USA 100, 5974\u20135979 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"464_CR14","first-page":"362","volume":"1","author":"D Porter","year":"2003","unstructured":"Porter, D. et al. Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res 1, 362\u2013375 (2003).","journal-title":"Mol. Cancer Res"},{"key":"464_CR15","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1158\/0008-5472.CAN-12-0636","volume":"72","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res 72, 4574\u20134586 (2012).","journal-title":"Cancer Res"},{"key":"464_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1155\/2010\/829358","volume":"33","author":"CB Moelans","year":"2010","unstructured":"Moelans, C. B., de Weger, R. A., Monsuur, H. N., Maes, A. H. & van Diest, P. J. Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Anal. Cell Pathol. (Amst.) 33, 165\u2013173 (2010).","journal-title":"Anal. Cell Pathol. (Amst.)"},{"key":"464_CR17","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-19-2563","volume":"26","author":"F Pareja","year":"2020","unstructured":"Pareja, F. et al. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma. Clin. Cancer Res 26, 3682\u20133693 (2020).","journal-title":"Clin. Cancer Res"},{"key":"464_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/bcr1286","volume":"7","author":"MC Adriance","year":"2005","unstructured":"Adriance, M. C., Inman, J. L., Petersen, O. W. & Bissell, M. J. Myoepithelial cells: good fences make good neighbors. Breast Cancer Res 7, 190\u2013197 (2005).","journal-title":"Breast Cancer Res"},{"key":"464_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/bcr459","volume":"4","author":"MA Deugnier","year":"2002","unstructured":"Deugnier, M. A., Teuli\u00e8re, J., Faraldo, M. M., Thiery, J. P. & Glukhova, M. A. The importance of being a myoepithelial cell. Breast Cancer Res 4, 224\u2013230 (2002).","journal-title":"Breast Cancer Res"},{"key":"464_CR20","first-page":"1","volume":"69","author":"M Sopel","year":"2010","unstructured":"Sopel, M. The myoepithelial cell: its role in normal mammary glands and breast cancer. Folia Morphol. (Warsz.) 69, 1\u201314 (2010).","journal-title":"Folia Morphol. (Warsz.)"},{"key":"464_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1101\/sqb.2005.70.013","volume":"70","author":"MJ Bissell","year":"2005","unstructured":"Bissell, M. J., Kenny, P. A. & Radisky, D. C. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb. Symp. Quant. Biol. 70, 343\u2013356 (2005).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"464_CR22","first-page":"1949","volume":"3","author":"MD Sternlicht","year":"1997","unstructured":"Sternlicht, M. D., Kedeshian, P., Shao, Z. M., Safarians, S. & Barsky, S. H. The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res 3, 1949\u20131958 (1997).","journal-title":"Clin. Cancer Res"},{"key":"464_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr260","volume":"3","author":"SR Lakhani","year":"2001","unstructured":"Lakhani, S. R. & O\u2019Hare, M. J. The mammary myoepithelial cell\u2013Cinderella or ugly sister? Breast Cancer Res 3, 1\u20134 (2001).","journal-title":"Breast Cancer Res"},{"key":"464_CR24","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1038\/sj.onc.1203677","volume":"19","author":"M Nguyen","year":"2000","unstructured":"Nguyen, M. et al. The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene 19, 3449\u20133459 (2000).","journal-title":"Oncogene"},{"key":"464_CR25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/path.1483","volume":"201","author":"JL Jones","year":"2003","unstructured":"Jones, J. L., Shaw, J. A., Pringle, J. H. & Walker, R. A. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J. Pathol. 201, 562\u2013572 (2003).","journal-title":"J. Pathol."},{"key":"464_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10911-005-9585-5","volume":"10","author":"SH Barsky","year":"2005","unstructured":"Barsky, S. H. & Karlin, N. J. Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J. Mammary Gland Biol. Neoplasia 10, 249\u2013260 (2005).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"464_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","volume":"13","author":"M Hu","year":"2008","unstructured":"Hu, M. et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13, 394\u2013406 (2008).","journal-title":"Cancer Cell"},{"key":"464_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0306-9877(97)90022-0","volume":"48","author":"MD Sternlicht","year":"1997","unstructured":"Sternlicht, M. D. & Barsky, S. H. The myoepithelial defense: a host defense against cancer. Med Hypotheses 48, 37\u201346 (1997).","journal-title":"Med Hypotheses"},{"key":"464_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.prp.2008.08.009","volume":"205","author":"X Zhang","year":"2009","unstructured":"Zhang, X. et al. Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion. Pathol. Res Pr. 205, 375\u2013385 (2009).","journal-title":"Pathol. Res Pr."},{"key":"464_CR30","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1186\/bcr653","volume":"5","author":"YG Man","year":"2003","unstructured":"Man, Y. G. et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res 5, R231\u2013R241 (2003).","journal-title":"Breast Cancer Res"},{"key":"464_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yexcr.2004.08.037","volume":"301","author":"YG Man","year":"2004","unstructured":"Man, Y. G. & Sang, Q. X. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the \u201cprotease-centered\u201d hypothesis. Exp. Cell Res 301, 103\u2013118 (2004).","journal-title":"Exp. Cell Res"},{"key":"464_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17\u201332 (2004).","journal-title":"Cancer Cell"},{"key":"464_CR33","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.ajpath.2015.07.004","volume":"185","author":"TD Russell","year":"2015","unstructured":"Russell, T. D. et al. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression. Am. J. Pathol. 185, 3076\u20133089 (2015).","journal-title":"Am. J. Pathol."},{"key":"464_CR34","doi-asserted-by":"publisher","first-page":"e0201370","DOI":"10.1371\/journal.pone.0201370","volume":"13","author":"HM Duivenvoorden","year":"2018","unstructured":"Duivenvoorden, H. M., Spurling, A., O\u2019Toole, S. A. & Parker, B. S. Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers. PLoS One 13, e0201370 (2018).","journal-title":"PLoS One"},{"key":"464_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12125-5","volume":"10","author":"L Ding","year":"2019","unstructured":"Ding, L. et al. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. Nat. Commun. 10, 4182 (2019).","journal-title":"Nat. Commun."},{"key":"464_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1078-0432.CCR-13-1504","volume":"20","author":"MD Allen","year":"2014","unstructured":"Allen, M. D. et al. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of \u03b1v\u03b26 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin. Cancer Res 20, 344\u2013357 (2014).","journal-title":"Clin. Cancer Res"},{"key":"464_CR37","doi-asserted-by":"publisher","first-page":"11466","DOI":"10.1074\/jbc.M117.775080","volume":"292","author":"PK Lo","year":"2017","unstructured":"Lo, P. K. et al. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma. J. Biol. Chem. 292, 11466\u201311484 (2017).","journal-title":"J. Biol. Chem."},{"key":"464_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-1068-7","volume":"19","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. TGF-\u03b21 stimulates epithelial-mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer. Cancer Cell Int 19, 343 (2019).","journal-title":"Cancer Cell Int"},{"key":"464_CR39","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-13-0012","volume":"73","author":"MW Pickup","year":"2013","unstructured":"Pickup, M. W. et al. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-\u03b2-deficient mouse mammary carcinomas. Cancer Res 73, 5336\u20135346 (2013).","journal-title":"Cancer Res"},{"key":"464_CR40","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1039\/c5ib00040h","volume":"7","author":"I Acerbi","year":"2015","unstructured":"Acerbi, I. et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr. Biol. (Camb.) 7, 1120\u20131134 (2015).","journal-title":"Integr. Biol. (Camb.)"},{"key":"464_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41563-020-00849-5","volume":"20","author":"O Maller","year":"2021","unstructured":"Maller, O. et al. Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression. Nat. Mater. 20, 548\u2013559 (2021).","journal-title":"Nat. Mater."},{"key":"464_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-15","volume":"10","author":"C Kretschmer","year":"2011","unstructured":"Kretschmer, C. et al. Identification of early molecular markers for breast cancer. Mol. Cancer 10, 15 (2011).","journal-title":"Mol. Cancer"},{"key":"464_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1083\/jcb.201402006","volume":"207","author":"F Klingberg","year":"2014","unstructured":"Klingberg, F. et al. Prestress in the extracellular matrix sensitizes latent TGF-\u03b21 for activation. J. Cell Biol. 207, 283\u2013297 (2014).","journal-title":"J. Cell Biol."},{"key":"464_CR44","first-page":"7091","volume":"61","author":"BS Nielsen","year":"2001","unstructured":"Nielsen, B. S. et al. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 61, 7091\u20137100 (2001).","journal-title":"Cancer Res"},{"key":"464_CR45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","volume":"185","author":"T Risom","year":"2022","unstructured":"Risom, T. et al. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell 185, 299\u2013310.e218 (2022).","journal-title":"Cell"},{"key":"464_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nmat3960","volume":"13","author":"A Elosegui-Artola","year":"2014","unstructured":"Elosegui-Artola, A. et al. Rigidity sensing and adaptation through regulation of integrin types. Nat. Mater. 13, 631\u2013637 (2014).","journal-title":"Nat. Mater."},{"key":"464_CR47","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1083\/jcb.201802144","volume":"217","author":"OK Sirka","year":"2018","unstructured":"Sirka, O. K., Shamir, E. R. & Ewald, A. J. Myoepithelial cells are a dynamic barrier to epithelial dissemination. J. Cell Biol. 217, 3368\u20133381 (2018).","journal-title":"J. Cell Biol."},{"key":"464_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-022-00464-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-022-00464-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-022-00464-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T11:08:03Z","timestamp":1663672083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-022-00464-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["464"],"URL":"https:\/\/doi.org\/10.1038\/s41523-022-00464-4","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"109"}}